Canada
· Delayed Price · Currency is CAD InnoCan Pharma Company Description
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
The company operates in two segments, Pharmaceuticals and Consumer Wellness. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for epilepsy and pain management.
The company is also involved in the development and sale of CBD-integrated pharmaceuticals and topical products.
In addition, it develops and markets a portfolio of self-care products for healthier lifestyle. The company offers its products under the Innocan Pharma, R&G Relief & Go, Shir, Synony, and Add On trade names.
InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
| Country | Canada |
| Founded | 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Iris Bincovich |
Contact Details
Address: 1015, 926 – 5 Avenue SW Calgary, T2P 0N7 Canada | |
| Phone | 403-777-1519 |
| Website | innocanpharma.com |
Stock Details
| Ticker Symbol | INNO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA45783P1027 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Iris Bincovich | Chief Executive Officer |
| Nelson Halpern | Chief Financial Officer |
| Roni Kamhi | Chief Operating Officer |